| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues, net | 43,353,235 | 43,358,847 | 47,328,701 | 53,084,883 |
| Cost of revenues (including cost of revenues from related parties of 4,018,377 and 2,039,492 for the three months ended september 30, 2025 and 2024, and 12,144,907 and 7,452,954 for the nine months ended september 30, 2025 and 2024, respectively) | 12,741,748 | 13,348,270 | 9,595,617 | 9,845,793 |
| Gross profit | 30,611,487 | 30,010,577 | 37,733,084 | 43,239,090 |
| Selling, general and administrative expenses (including selling, general and administrative expenses from related parties of 154,063 and nil for the three months ended september 30, 2025 and 2024, and 569,830 and nil for the nine months ended september 30, 2025 and 2024, respectively) | 14,730,247 | 15,456,385 | 13,531,010 | 16,597,032 |
| Stock-based compensation | 0 | - | - | 12,807,455 |
| Total operating expenses | 14,730,247 | 15,456,385 | 13,531,010 | 29,404,487 |
| Income from operations | 15,881,240 | 14,554,192 | 24,202,074 | 13,834,603 |
| Interest income | 120,384 | 22,882 | 55,333 | 7,950 |
| Interest expense | 48,635 | 49,651 | 6,207 | 5,466 |
| Other income (including other income from related parties of 3,069 and nil for the three months ended september 30, 2025 and 2024, and 3,069 and nil for the nine months ended september 30, 2025 and 2024, respectively) | 2,526,035 | 33,771 | 151,328 | 65,922 |
| Other expenses | 6,564 | 1,132,465 | 1,697,259 | 795,158 |
| Gain on redemption of life insurance policies | 0 | 0 | 8,746,138 | - |
| Change in fair value of cryptocurrencies | 34,404 | 111,632 | - | - |
| Gain on disposal of subsidiary | 0 | 0 | - | - |
| Total other income (expenses) | 2,625,624 | -1,013,831 | 7,249,333 | -726,752 |
| Income before income taxes | 18,506,864 | 13,540,361 | 31,451,407 | 13,107,851 |
| Income tax expense | 5,673,538 | 11,100,509 | 9,959,457 | 10,273,384 |
| Net income | 12,833,326 | 2,439,852 | 21,491,950 | 2,834,467 |
| Less net income (loss) attributable to non-controlling interests | 8,690 | -18,388 | -10,496 | 1,573 |
| Net income attributable to sbc medical group holdings incorporated | 12,824,636 | 2,458,240 | 21,502,446 | 2,832,894 |
| Net income per share attributable to sbc medical group holdings incorporated - basic | 0.12 | 0.02 | 0.21 | 0.03 |
| Net income per share attributable to sbc medical group holdings incorporated - diluted | 0.12 | 0.02 | 0.21 | 0.03 |
| Weighted average shares outstanding - basic | 102,642,634 | 103,507,249 | 103,276,637 | 95,095,144 |
| Weighted average shares outstanding - diluted | 102,642,634 | 103,507,249 | 103,276,637 | 95,095,144 |
SBC Medical Group Holdings Inc (SBC)
SBC Medical Group Holdings Inc (SBC)